Episode 316: Career Development and Advances in Retina Therapeutics with Dr. Thomas Ciulla

Dr. Thomas Ciulla joins to discuss developing a career as a researcher and transitioning to industry and major coming advances in delivery of retina therapeutic agents. Relevant Financial Disclosures: Dr. Sridhar is a consultant for Genentech, Regeneron, Allergan, Alcon, and Dorc. Dr. Ciulla is the Chief Medical Officer and Chief Development Officer at Clearside Bio. You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Om Podcasten

An informal yet insightful commentary featuring interviews and perspectives from leaders in vitreoretinal surgery as well as the next generation of retinal specialists